Docosahexaenoic acid supplementation failed to attenuate chronic alcoholic fatty liver in mice | Zendy

Yi Wang | Zendy; Yuying Zhao | Zendy; Mingzhuo Li | Zendy; Yunxuan Wang | Zendy; Shuqing Yu | Zendy; Tao Zeng | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Docosahexaenoic acid supplementation failed to attenuate chronic alcoholic fatty liver in mice

Author(s) -

Yi Wang,

Yuying Zhao,

Mingzhuo Li,

Yunxuan Wang,

Shuqing Yu,

Tao Zeng

Publication year - 2016

Publication title -

acta biochimica et biophysica sinica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.771

H-Index - 57

eISSN - 1745-7270

pISSN - 1672-9145

DOI - 10.1093/abbs/gmw016

Subject(s) - docosahexaenoic acid , fatty liver , chronic alcoholic , medicine , endocrinology , chemistry , fatty acid , biochemistry , polyunsaturated fatty acid , disease

The roles of n-3 polyunsaturated fatty acids (PUFAs) including docosahexaenoic acid (DHA) in alcoholic fatty liver (AFL) have been investigated in a series of studies. DHA andDHA-rich fish oil were found to provide protection against acute AFL [1,2], while their effects on chronic AFL is still a controversial issue. Although Song et al. [3] found that DHA and arachidonic acid prevented chronic AFL, several

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research